Picture of TG Therapeutics logo

TGTX — TG Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapMomentum Trap

Brief: Tg Therapeutics Provides Business Update And Reports Fourth Quarter And Year-End 2022 Financial Results

Feb 28 (Reuters) - Tg Therapeutics Inc  TGTX.O :
    * TG THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
FOURTH
QUARTER AND YEAR-END 2022 FINANCIAL RESULTS
    * SEES CASH, INVESTMENTS AS OF DEC 31, 2022, WITH $45.0
MILLION
UNDER TERM LOAN, TO BE SUFFICIENT TO FUND  PLANNED OPERATIONS
INTO MID-2024
    * QTRLY BASIC AND DILUTED NET LOSS PER COMMON SHARE $0.39
    * Q4 EARNINGS PER SHARE VIEW $-0.26 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX2pPFrL 
Further company coverage:  TGTX.O

Recent news on TG Therapeutics

See all news